The Business Research Company’s latest report Cardiovascular Drugs Global Market Report 2020 covers Cardiovascular Drugs market drivers, Cardiovascular Drugs market trends, Cardiovascular Drugs market segments, Cardiovascular Drugs market growth rate, Cardiovascular Drugs market major players, and Cardiovascular Drugs market size. The report provides in-depth analysis of the impact of COVID-19 on the Cardiovascular Drugs industry, along with revised market numbers due to the effects of the coronavirus.
Cardiovascular Drugs Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
Request For The Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=2134&type=smp
The global cardiovascular drugs market is expected to decline from $92.5 billion in 2019 to $85.4 billion in 2020 at a compound annual growth rate (CAGR) of -7.8%. The decline is mainly because of the lockdown measures due to the COVID-19 outbreak. The decrease in the number of cardiac surgeries due to re-scheduling of surgeries, cancellations and no-show by patients, decrease in consultations due to restrictions by government and health authorities to provide only emergency services, and less heart disease admissions contribute to this decline. However, the decline is not significant as research showed that the COVID-19 patients developed cardiovascular complications, and therefore health authorities advised COVID-19 and non-COVID-19 cardiac patients to continue the use of CVD drugs. The market is then expected to recover and grow at a CAGR of 3% from 2021 and reach $106.1 billion in 2023.
The report covers the cardiovascular drugs market’s segments-
1) By Type: Anti-Hypertensive Drugs, Hypolipidemic, Anti Thrombotic, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs).
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others.
3) By Route Of Administration: Oral, Parenteral, Others.
4) By Drug Classification: Branded Drugs, Generic Drugs.
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
Avail up to 50% off on ALL research reports at: https://www.thebusinessresearchcompany.com/global-market-reports Offer applies until Dec 31st.
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 20 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]